|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - GBX | -.--% |
|
-.--% | - |
| Jul. 24 | Reckitt Benckiser sells Hygiene business in Russia but keeps Health | AN |
| Jul. 24 | Reckitt sells Russian hygiene asset; US blow for Wise | AN |
Company Valuation: Unilever
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 120,277 | 119,234 | 109,432 | 136,147 | 121,203 | 115,435 | - | - |
| Change | - | -0.87% | -8.22% | 24.41% | -10.98% | -4.76% | - | - |
| Enterprise Value (EV) 1 | 145,787 | 142,910 | 133,089 | 160,666 | 144,279 | 139,195 | 138,385 | 137,555 |
| Change | - | -1.97% | -6.87% | 20.72% | -10.2% | -3.52% | -0.58% | -0.6% |
| P/E | 20.2x | 15.8x | 17.1x | 24x | 21.5x | 17.7x | 16.4x | 15.6x |
| PBR | 7.03x | 6.27x | 6.05x | 6.81x | 7.82x | 7.19x | 6.58x | 6.07x |
| PEG | - | 0.5x | -1.2x | -2.3x | 40.28x | 1x | 2.13x | 3.12x |
| Capitalization / Revenue | 2.29x | 1.98x | 1.84x | 2.24x | 2.4x | 2.23x | 2.15x | 2.08x |
| EV / Revenue | 2.78x | 2.38x | 2.23x | 2.64x | 2.86x | 2.69x | 2.58x | 2.48x |
| EV / EBITDA | 12.8x | 12.5x | 11.6x | 12.5x | 12.7x | 11.9x | 11.3x | 10.7x |
| EV / EBIT | 15.1x | 14.8x | 13.4x | 14.4x | 14.3x | 13.4x | 12.7x | 12.1x |
| EV / FCF | 22.8x | 25.3x | 18.8x | 23.2x | 24.4x | 22.5x | 20.3x | 18.9x |
| FCF Yield | 4.39% | 3.96% | 5.33% | 4.31% | 4.1% | 4.44% | 4.91% | 5.3% |
| Dividend per Share 2 | 1.954 | 1.883 | 1.921 | 1.979 | 1.82 | 1.91 | 1.991 | 2.088 |
| Rate of return | 3.7% | 3.55% | 3.9% | 3.2% | 3.27% | 3.56% | 3.71% | 3.89% |
| EPS 2 | 2.61 | 3.364 | 2.88 | 2.576 | 2.59 | 3.038 | 3.272 | 3.435 |
| Distribution rate | 74.8% | 56% | 66.7% | 76.8% | 70.3% | 62.9% | 60.8% | 60.8% |
| Net sales 1 | 52,444 | 60,073 | 59,604 | 60,761 | 50,503 | 51,762 | 53,607 | 55,575 |
| EBITDA 1 | 11,382 | 11,408 | 11,510 | 12,803 | 11,394 | 11,687 | 12,265 | 12,827 |
| EBIT 1 | 9,636 | 9,683 | 9,931 | 11,179 | 10,084 | 10,387 | 10,868 | 11,395 |
| Net income 1 | 6,049 | 7,642 | 6,487 | 5,744 | 9,469 | 6,546 | 6,782 | 7,270 |
| Net Debt 1 | 25,510 | 23,676 | 23,657 | 24,519 | 23,076 | 23,760 | 22,950 | 22,119 |
| Reference price 2 | 52.85 | 53.04 | 49.26 | 61.87 | 55.70 | 53.62 | 53.62 | 53.62 |
| Nbr of stocks (in thousands) | 2,275,903 | 2,247,919 | 2,221,344 | 2,200,509 | 2,175,828 | 2,152,978 | - | - |
| Announcement Date | 2/10/22 | 2/9/23 | 2/8/24 | 2/13/25 | 2/12/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 21.71x | 4.22x | 15.46x | 2.89% | 343B | ||
| 24.62x | 3.7x | 15.54x | 2.32% | 72.62B | ||
| 44.63x | 7.16x | 31.07x | 2.11% | 52.33B | ||
| 20.23x | 2.84x | 11.79x | 4.4% | 37.02B | ||
| 77.99x | 2.32x | 13.97x | 1.75% | 29.05B | ||
| 15.97x | 1.53x | 8.71x | 3.32% | 19.31B | ||
| 17.99x | 1.3x | 7.75x | 1.31% | 19.29B | ||
| 21.35x | 1.54x | 9.81x | 2.42% | 17.81B | ||
| 44.98x | 6.51x | 31.11x | 1.6% | 11.26B | ||
| Average | 32.16x | 3.46x | 16.14x | 2.46% | 66.88B | |
| Weighted average by Cap. | 26.80x | 4.02x | 16.19x | 2.72% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ULVR Stock
- ULVR Stock
- Valuation Unilever
Select your edition
All financial news and data tailored to specific country editions
















